Oslo, Norway, November 25, 2021: Radforsk Investeringsstiftelse, a legal person closely associated with a person discharging managerial responsibilities in Ultimovacs ASA has notified the company of a pledge of shares in Ultimovacs ASA.
Please refer to the attached for further information.
This information made public by Ultimovacs ASA pursuant to article 19 of the EU Market Abuse Regulation and is subject to the disclosure requirements pursuant to Section 5-12 the Norwegian Securities Trading Act.
For further information, please contact:
Jónas Einarsson, Chairman of the Board of Directors of Ultimovacs ASA
Email: je@radforsk.no
Phone: +47 480 96 355
Hans Vassgård Eid, CFO
Email: hans.eid@ultimovacs.com
Phone: +47 482 48632
Attachment
– ENERGIZE is the First Study to Demonstrate Efficacy of an Oral Treatment for Non-Transfusion-Dependent Alpha-…
MINNEAPOLIS, June 14, 2024 (GLOBE NEWSWIRE) -- FOXO Technologies Inc. (NYSE American: FOXO) (the “Company”…
Entrepreneur Of The Year celebrates ambitious entrepreneurs who are shaping the future DALLAS, June 14,…
Marcroft Medical proudly announces its launch as a trusted distributor of high-quality medical equipment, offering…
NEW YORK, June 14, 2024 /PRNewswire/ -- The global smart weight, body composition, and BMI scales market size…
SARATOGA SPRINGS, N.Y., June 14, 2024 /PRNewswire/ -- Aptihealth, Inc. ("Aptihealth") was recently made aware…